Results 41 to 50 of about 3,619 (165)
Addiction, EarlyView.Abstract Background and aims Current treatment options for alcohol use disorder are limited. Transcranial direct current stimulation has been proposed as a therapeutic approach, but evidence remains scarce. This study aimed to compare active vs. sham transcranial direct current stimulation to evaluate its efficacy and safety in reducing alcohol ...
Benoit Trojak +19 more
wiley +1 more source
Addiction, EarlyView.Abstract Background and aims Originally developed for clinical screening for hazardous alcohol use, the Alcohol Use Disorder Identification Test – Consumption (AUDIT‐C) is also widely used in epidemiological research and monitoring. However, its cutoff values may not suit all purposes, and evidence on its predictive validity is limited. We examined how
Pia Mäkelä +7 more
wiley +1 more source
Acamprosate for treatment of alcohol dependence: mechanisms, efficacy, and clinical utility
Therapeutics and Clinical Risk Management, 2012 Katie Witkiewitz, Kimber Saville, Kacie HamreusDepartment of Psychology, Washington State University Vancouver, Vancouver, WA, USAAbstract: Acamprosate, or N-acetyl homotaurine, is an N-methyl-D-aspartate receptor modulator approved by the Food and Drug ...
Witkiewitz K, Saville KA, Hamreus K
doaj
RNA biomarkers for alcohol use disorder
Frontiers in Molecular Neuroscience, 2022 Alcohol use disorder (AUD) is highly prevalent and one of the leading causes of disability in the US and around the world. There are some molecular biomarkers of heavy alcohol use and liver damage which can suggest AUD, but these are lacking in ...
Laura B. Ferguson +7 more
doaj +1 more source
The American Journal on Addictions, EarlyView.Abstract Background and Objectives Readmission to residential treatment increases healthcare costs, strains publicly funded systems, and may not adequately meet clients' needs. This study examined rates and predictors of readmission to residential treatment among clients transitioned from detoxification services.
Abreham Mekonnen
wiley +1 more source
PLoS ONE, 2021 ObjectiveUpdate the evidence on use of pharmacotherapy for alcohol use disorder in a Canadian population.MethodsUsing whole-population administrative data from Manitoba, Canada, we identified all residents age 12+ who were first diagnosed with alcohol ...
Geoffrey Konrad +9 more
doaj +1 more source
EClinicalMedicine, 2021 Background: Although tinnitus has a prevalence between 20 and 42.8%, the currently recommended management for tinnitus, such as tinnitus support and psychologic therapies, are relatively time-consuming and expensive.
Jiann-Jy Chen +20 more
doaj +1 more source
Drug and Alcohol Review, Volume 45, Issue 5, July 2026.ABSTRACT Introduction Interest in managing alcohol‐related risks through temporary abstinence challenges has grown significantly. Studies on abstinence challenges in the general population show improvements in for example mental health, blood pressure, insulin resistance and alcohol consumption, but studies in clinical samples are lacking, including ...
Stina Ingesson‐Hammarberg +5 more
wiley +1 more source
Drug and Alcohol Review, Volume 45, Issue 5, July 2026.ABSTRACT Introduction Gabapentin is widely prescribed off‐label to treat pain. However, there are concerns about the proliferation of medical and non‐medical use, and the potential increased risk of overdose death associated with concurrent opioid use.
Evelyne Marie Piret +7 more
wiley +1 more source
Alcohol treatment discussions and clinical outcomes among patients with alcohol-related cirrhosis
BMC Gastroenterology, 2023 Background Alcohol cessation is the cornerstone of treatment for alcohol-related cirrhosis. This study evaluated associations between medical conversations about alcohol use disorder (AUD) treatment, AUD treatment engagement, and mortality.
Wheytnie Alexandre +10 more
doaj +1 more source